Leveraging Medical Affairs Expertise for Accelerated Trial Timelines and Stakeholder Engagement
Why deploying Medical Science Liaisons (MSLs) in the clinical trial setting can positively impact enrollment rates and overall site management.
As clinical trials become increasingly complex and patient recruitment delays continue to be an ever-present challenge, engaging Medical Affairs field teams early to provide scientific support to clinical trial sites is proving to be an effective means for accelerating study timelines and keeping patient enrollment and clinical study completion on track.
Doing so, however, requires clear and effective communication between Medical Science Liaisons (MSLs), Clinical Operations and site staff, and thoughtful delineation of MSL roles and responsibilities to meet the specific needs of each clinical trial.
Download the white paper below to learn how deploying MSLs in the clinical trial setting can positively impact enrollment rates and overall site management in a time where the increasing complexity of therapeutic modalities, economic pressure, greater focus on patient centricity, and an expanding stakeholder ecosystem have made clinical trials increasingly complex to complete.